Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > @Anima on CEO.CA has narrowed it down
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(18)
•••
Comment by Enoughon Aug 30, 2022 3:18pm
90 Views
Post# 34930387

RE:RE:RE:@Anima on CEO.CA has narrowed it down

RE:RE:RE:@Anima on CEO.CA has narrowed it down
G1945V wrote:
Enough wrote: GE has thier own patented system, as I understand it.
VPTRs original system is off patent
This makes no sense that GE would use VPTs software -off patent-and not reveal it. it would be material news
You guys are sytretching or misrepresenting to make people believe this
If its true why doesnt VPT announce it.
Here is the patent Echopac uses

https://patents.google.com/patent/US8150128B2/en


No one is saying for you to believe what is being posted here.
Do your own due diligence and go from there. 

In addition, I'm sure that all financials and MD&A can be read and understood without anyone having to recount them over here.

Good luck.

G1945V


I agree -why post financials and MDA
Why not just have jo boy post 20x a day about stuff that never happens and cant be verified
Buyouts and sales that are right around the corner
Why hear the truth-much better to have us read avout lube, and what's going to happen-not what is actually happening

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities